Indivior (LON:INDV) Stock Price Down 22.9% – Here’s Why

Indivior PLC (LON:INDV)’s share price was down 22.9% during mid-day trading on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 669.50 ($8.46). Approximately 1,917,540 shares changed hands during mid-day trading, an increase of 170% from the average daily volume of 710,287 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 1,800 ($22.74) price objective on shares of Indivior in a report on Tuesday, December 17th.

Indivior Stock Down 5.9 %

The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06. The stock has a market cap of £1.08 billion, a price-to-earnings ratio of -570.87, a PEG ratio of -5.57 and a beta of 0.19. The business’s fifty day moving average is GBX 920.11 and its two-hundred day moving average is GBX 850.81.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.